Evaluation of the tannic acid inhibitory effect against the NorA efflux pump of Staphylococcus aureus

Microbial Pathogenesis

Volumn 97, Issue , 2016, Pages 9-13

  Tintino, Saulo R ^a   Oliveira Tintino, Cícera D M ^a   Campina, Fábia F ^a   Silva, Raimundo L P ^a   Costa, Maria do S ^a   Menezes, Irwin R A ^a   Calixto Júnior, João T ^a   Siqueira Junior, José P ^b   Coutinho, Henrique D M ^a   Leal Balbino, Tereza C ^c   Balbino, Valdir Q ^c  

^a URCA   (Brazil)

^b FEDERAL UNIVERSITY OF PARAÍBA   (Brazil)

^c FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

Author keywords

Antibiotic resistance; Efflux pumps; NorA; Staphylococcus aureus; Tannic acid

Indexed keywords

BACTERIAL PROTEIN; CARBONYL CYANIDE CHLOROPHENYLHYDRAZONE; CHLORPROMAZINE; ETHIDIUM BROMIDE; NORA EFFLUX PROTEIN; NORFLOXACIN; PHENYLALANYL ARGINYL BETA NAPHTHYLAMIDE; PROTEIN INHIBITOR; TANNIN; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; ENZYME INHIBITOR; ETHIDIUM; MULTIDRUG RESISTANCE PROTEIN; NORA PROTEIN, STAPHYLOCOCCUS; TANNIN DERIVATIVE;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; DRUG INHIBITION; DRUG MECHANISM; DRUG POTENTIATION; DRUG TRANSPORT; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; MICROBIAL SENSITIVITY TEST;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; ENZYME INHIBITORS; ETHIDIUM; MICROBIAL SENSITIVITY TESTS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; STAPHYLOCOCCUS AUREUS; TANNINS;

EID: 84970016079     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1016/j.micpath.2016.04.003     Document Type: Article

References (37)

1. Karchmer A.W. Nosocomial bloodstream infections: organisms, risk factors, and implications. Clin. Infect. Dis. 2000, 31:39-143.
2. Neu H.C. The crisis in antibiotic resistance. Science 1992, 257:1064-1073.
3. Normark B.H., Normark S. Evolution and spread of antibiotic resistance. J. Intern. Med. 2002, 252:91-106.
4. Kumar S., Mukherjee M.M., Varela M.F. Modulation of bacterial multidrug resistance efflux pumps of the major facilitator superfamily. Inter. J. Bac. 2013, 2013(2013):1-15.
5. Levy S.B. Active efflux mechanisms for antimicrobial resistance. Antimicrob. Ag Chemothep. 1992, 36:695-703.
6. Higgins C.F. Multiple molecular mechanisms for multidrug resistance transporters. Nature 2007, 446:749-757.
7. Henderson P.J. Studies of translocation catalysis. Biosci. Rep. 1991, 11:453-477.
8. Poolman B., Konings W.N. Secondary solute transport in bacteria. Biochim. Biophy. Act 1993, 1183:5-39.
9. Parr T.R., Saier M.H. The bacterial phosphotransferase system as a potential vehicle for the energy of novelantibiotics. Research Microbiol 1992, 143:443-447.
10. Kumar S., Smith K.P., Floyd J.L., Varela M.F. Cloning and molecular analysis of a mannitol operon of phosphoenolpyruvate-dependent phosphotransferase (PTS) type from Vibrio cholerae O395. Archives Microbiol. 2011, 193:201-208.
11. Holden M.T., Feil E.J., Lindsay J.A., Peacock S.J., Day N.P., Enright M.C., Foster T.J., et al. Complete genomes of two clinical Staphylococcus aureus strains: evidence for the rapid evolution of virulence and drug resistance. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:9786-9979.
12. Carbon C. MRSA and MRSE: is there an answer?. Clin. Microbiol. Infect. 2000, 6:17-22.
13. Marchese A., Schito G.C., Debbia E.A. Evolution of antibiotic resistance in gram-positive pathogens. J. Chemother. 2000, 12:459-462.
14. Paulsen I.T., Skurray R.A., Tam R., Saier M.H., Turner R.J., Weiner J.H., et al. The SMR family: a novel family of multidrug efflux proteins involved with the efflux of lipophilic drugs. Mol. Microbiol. 1996, 19:1167-1175.
15. Tennent J.M., Lyon B.R., Midgley M., Jones I.G., Purewal A.S., Skurray R.A. Physical and biochemical characterization of the qacA gene encoding antiseptic and disinfectant resistance in Staphylococcus aureus. J. Gen. Microbiol. 1989, 135:1-10.
16. Grinius L., Dreguniene G., Goldberg E.B., Liao C.H., Projan S.J. A staphylococcal multidrug resistance gene product is a member of a new protein family. Plasmid 1992, 27:119-129.
17. Yoshida H., Bogaki M., Nakamura S., Ubukata K., Konno M. Nucleotide sequence and characterization of the Staphylococcus aureus norA gene, which confers resistance to quinolones. J. Bacteriol. 1990, 172:6942-6949.
18. Littlejohn T.G., Paulsen I.T., Gillespie M.T., Tennent J.M., Midgley M., Jones I.G., et al. Substrate specificity and energetics of antiseptic and disinfectant resistance in Staphylococcus aureus. FEMS Microbiol. Lett. 1992, 74:259-265.
19. Paulsen I.T., Brown M.H., Skurray R.A. Proton-dependent multidrug efflux systems. Microbiol 1996, 60:575-608.
20. Poole K. Efflux-mediated resistance to fluoroquinolones in gram-positive bacteria and the mycobacteria. Antimicrob. Agents Chemother. 2000, 44:2595-2599.
21. Ng E.Y., Trucksis M., Hooper D.C. Quinolone resistance mediated by norA: physiologic characterization and relationship to flqB, a quinolone resistance locus on the Staphylococcus aureus chromosome. Antimicrob. Agents Chemother. 1994, 38:1345-1355.
22. CLSI - Clinical and Laboratory Standards Institute Performance Standards of Antimicrobial Disk Susceptibility Test: Ninth Informational Supplement 2008, 120-126. NCCLS document M100-S9, NIH, Wayne, PA.
23. Kaatz G.W., Seo S.M. Inducible NorA-mediated multidrug resistance in Staphylococcus aureus. Antimicrob. agents Chemothera 1995, 39:2650-2655.
24. Davies J., Wright G.D. Bacterial resistance to aminoglycoside antibiotics. Trends Microbiol. 1997, 5(6):234-240.
25. Goswitz J.J., Willard K.E., Fasching C.E. Peterson LR.Detection of gyrA mutations associated with ciprofloxacin resistance in methicillin-resistant Staphylococcus aureus: analysis by polymerase chain reaction and automated direct DNA sequencing. Antimicrob. Agents Chemother. 1992, 36:1166-1169.
26. Hooper D.C., Wolfson J.S. Mode of action of the new quinolones: new data. Eur. J. Microbiol. Infect. Dis. 1991, 10:223-231.
27. Sreedharan S., Oram M., Jensen B., Peterson L.R., Fisher L.M. DNA gyrase gyrA mutations in ciprofloxacin-resistant strains of Staphylococcus aureus: close similarity with quinolone resistance mutations in Escherichia coli. J. Bacteriol. 1990, 172:7260-7262.
28. Trucksis M., Wolfson J.S., Hooper D.C. A novel locus conferring fluoroquinolone resistance in Staphylococcus aureus. J. Bacteriol. 1991, 173:5854-5860.
29. Kaatz G.W., Seo S.M., Ruble C.A. Mechanisms of fluoroquinolone resistance in Staphylococcus aureus. J. Infect. Dis. 1990, 163:1080-1086.
30. Kaatz G.W., Seo S.M., Ruble C.A. Efflux-mediated fluoroquinolone resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 1993, 1993(37):1086-1094.
31. Pages J.M., Masi M., Barbe J. Inhibitors of efflux pumps in Gramnegative bacteria. Trends Mol. Med. 2005, 11:382-389.
32. Mallea M., Chevalier J., Eyraud A., Pages J.M. Inhibitors of antibiotic efflux pump in resistant Enterobacter aerogenes strains. Biochem. Biophys. Res. Commun. 2002, 293:1370-1373.
33. Kalia N.P., Mahajan P., Mehra R., Mehra R., Nargotra A., Sharma J.P., Koul S., Khan I.A. Capsaicin, a novel inhibitor of the NorA efflux pump, reduces the intracellular invasion of Staphylococcus aureus. J Antimicrob. Chemothera 2012, 67:2401-2408.
34. Holler J.G., Slotved H.C., Molgaard P., Olsen C.E., Christensen S.B. Chalcone inhibitors of the NorA efflux pump in Staphylococcus aureus whole cells and enriched everted membrane vesicles. Bioorg. Medi. Chem. 2012, 20:4514-4521.
35. Holler J.G., Christensen S.B., Slotved H.C., et al. Novel inhibitory activity of the Staphylococcus aureus NorA efflux pump by a kaempferol rhamnoside isolated from Persea lingue Nees. J. Antimicrob. Chemothera 2012, 67:1138-1144.
36. Chung K.T., Wong T.Y., Wei C.I., Huang Y.W., Lin Y. Tannins and human health: a review. Crit. Rev. Food Sci. Nutrit. 1998, 38:421-464.
37. Rothstein D.M., McGlynn M., Bernan V., McGahren J., Zaccardi J., Cekleniak N., et al. Detection of tetracyclines and efflux pump inhibitors. Antimicrob. Agents Chemother. 1993, 37:1624-1629.